2026 NPPES data Pediatric Endocrinology Physician NPI 1922639301
Verify on CMS →

GINA FERRARI

Pediatric Endocrinology Physician in SALINAS, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
316
Medicare Part D claims · 60 beneficiaries · Pediatric Endocrinology Physician avg: 151
Generic prescribing
23%
generic claims · 77% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$41.59
2 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: GINA FERRARI is a Pediatric Endocrinology Physician ([object Object]) practicing in SALINAS, California with a Medicare Part D prescribing footprint of 316 claims across 60 beneficiaries — 77% brand-name prescribing . Industry payments of $41.59 across 2 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: GINA FERRARI filed 316 Medicare Part D claims in 2023 across SALINAS, California. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

GINA FERRARI practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

GINA FERRARI at a glance

Quality data not reported

NPI registry status

Active

Issued 02/04/2020

NPI 1922639301

Primary specialty

Pediatric Endocrinology Physician

Niche

1,457 US NPIs in this specialty

Medicare Part D claims

316 109% vs specialty avg

2023 prescription claims

Specialty avg: 151

Specialty distribution in California

How Pediatric Endocrinology Physician compares to other specialties among California providers

California providers

Pediatric Endocrinology Physician share within California

1. Pediatric Endocrinology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pediatric Endocrinology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pediatric Endocrinology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pediatric Endocrinology Physician ABMS/AOA estimate

Est. board-certified rate (Pediatric Endocrinology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pediatric Endocrinology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

GINA FERRARI is a Pediatric Endocrinology Physician provider practicing in SALINAS, California, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1922639301. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

GINA FERRARI appears in the CMS NPPES registry as a Pediatric Endocrinology Physician provider at 355 ABBOTT ST STE 200, SALINAS, CA, 93901, with a listed phone of (831) 422-3636. NPI 1922639301 was issued on 02/04/2020. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FERRARI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 316 prescription claims written by this provider, covering 60 Medicare beneficiaries and totaling roughly $234K in drug spend, split 77% brand-name and 23% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pediatric Endocrinology Physician is a narrow specialty nationwide, with 1,457 enrolled providers across 51 states and an average of 151 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

355 ABBOTT ST STE 200
SALINAS, CA 93901

Provider Details

NPI 1922639301
Specialty Pediatric Endocrinology Physician
Gender Female
NPI Issued 02/04/2020

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GINA FERRARI. Source: openpaymentsdata.cms.gov.

Total received

$42

Largest payer

Lilly USA, LLC

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to GINA FERRARI. To verify GINA FERRARI's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

GINA FERRARI — brand share 77.0%
Specialty average (est.)

77% brand-name claims vs 23% generic, on 316 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

316
Total Claims
$234K
Total Drug Cost
60
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
552
Total Day Supply
16,365
Brand vs Generic
77% brand / 23% generic
Brand Drug Cost
$229K
Generic Drug Cost
$705

Patient Demographics

Average Patient Age
69.2 years
Avg HCC Risk Score
1.32
Gender Split
55% female / 45% male
Age Distribution
<65: 14, 65-74: 31, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ozempic
Semaglutide
55
Jardiance
Empagliflozin
50
Rybelsus
Semaglutide
30
Trulicity
Dulaglutide
24
Metformin Hcl
22
Metformin Hcl Er
Metformin Hcl
14
Basaglar Kwikpen U-100
"Insulin Glargine
N/A
Lantus Solostar
"Insulin Glargine
N/A

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Endocrinology Physician Overview

How GINA FERRARI fits within the Pediatric Endocrinology Physician landscape nationally.

1,457
Pediatric Endocrinology Physician Providers in US
51
States with Pediatric Endocrinology Physician
151
Avg Claims per Provider

GINA FERRARI's 316 claims are above the specialty average of 151.

Nearby Pediatric Endocrinology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as FERRARI.

Compare Pediatric Endocrinology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is GINA FERRARI's specialty?
GINA FERRARI specializes in Pediatric Endocrinology Physician and practices in SALINAS, California.
How much does GINA FERRARI prescribe under Medicare Part D?
In 2023, GINA FERRARI wrote 316 Medicare Part D claims totaling $234K in drug costs for 60 beneficiaries.
Where is GINA FERRARI located?
GINA FERRARI is located at 355 ABBOTT ST STE 200, SALINAS, CA, 93901. Phone: (831) 422-3636.
What is GINA FERRARI's NPI number?
GINA FERRARI's National Provider Identifier (NPI) is 1922639301, issued on 02/04/2020.
Does GINA FERRARI prescribe more brand-name or generic drugs?
GINA FERRARI's prescribing is 77% brand-name and 23% generic drugs by claim count, with $229K in brand drug costs.
How many Pediatric Endocrinology Physician providers are there in the US?
There are 1,457 Pediatric Endocrinology Physician providers across 51 states in the US. The average Pediatric Endocrinology Physician provider writes 151 Medicare Part D claims per year.
What drugs does GINA FERRARI prescribe most often?
Based on 2023 Medicare Part D data, GINA FERRARI's most frequently prescribed drugs include Ozempic, Jardiance, Rybelsus. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GINA FERRARI accept Medicare?
GINA FERRARI appears in CMS Medicare data with 316 Part D claims and 60 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GINA FERRARI's credentials?
GINA FERRARI's NPI is 1922639301. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology